Danielle R. Soenen, Ph.D. - Publications

Affiliations: 
2003 Scripps Research Institute, La Jolla, La Jolla, CA, United States 
Area:
synthetic organic chemistry

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Soenen DR, Vanderwal CD. ChemInform Abstract: Synthesis of Dialkyl Ether by Addition to Alkenes Cheminform. 41. DOI: 10.1002/chin.201015224  0.366
2005 Chou TC, Guan Y, Soenen DR, Danishefsky SJ, Boger DL. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice. Cancer Chemotherapy and Pharmacology. 56: 379-90. PMID 15875185 DOI: 10.1007/S00280-005-1019-Y  0.37
2003 Buck SB, Hardouin C, Ichikawa S, Soenen DR, Gauss CM, Hwang I, Swingle MR, Bonness KM, Honkanen RE, Boger DL. Fundamental role of the fostriecin unsaturated lactone and implications for selective protein phosphatase inhibition. Journal of the American Chemical Society. 125: 15694-5. PMID 14677930 DOI: 10.1021/Ja038672N  0.458
2003 Soenen DR, Hwang I, Hedrick MP, Boger DL. Multidrug resistance reversal activity of key ningalin analogues. Bioorganic & Medicinal Chemistry Letters. 13: 1777-81. PMID 12729663 DOI: 10.1016/S0960-894X(03)00294-4  0.424
2003 Soenen DR, Zimpleman JM, Boger DL. Synthesis and inverse electron demand Diels-Alder reactions of 3,6-bis(3,4-dimethoxybenzoyl)-1,2,4,5-tetrazine. The Journal of Organic Chemistry. 68: 3593-8. PMID 12713365 DOI: 10.1021/Jo020713V  0.572
2002 Lewy DS, Gauss CM, Soenen DR, Boger DL. Fostriecin: chemistry and biology. Current Medicinal Chemistry. 9: 2005-32. PMID 12369868 DOI: 10.2174/0929867023368809  0.436
2000 Boger DL, Soenen DR, Boyce CW, Hedrick MP, Jin Q. Total synthesis of ningalin B utilizing a heterocyclic azadiene Diels-Alder reaction and discovery of a new class of potent multidrug resistant (MDR) reversal agents. The Journal of Organic Chemistry. 65: 2479-83. PMID 10789460 DOI: 10.1021/Jo9916535  0.539
Show low-probability matches.